Single-cell and spatial technologies reveal UC pathogenesis insights but face sample size and phenotype heterogeneity limits
New tech maps ulcerative colitis cells, but small study groups limit what we know for sure yet
This systematic review evaluated single cell RNA sequencing, spatial transcriptomic, and proteomic technologies in adult ulcerative colitis …
New technology maps exactly which cells drive ulcerative colitis inflammation, helping explain why some patients respond to medicine while o…
Over 100 agents in development for moderate to severe ulcerative colitis, with early remission data for one class
Many new ulcerative colitis drugs are in development, with early trial results for one type
A review describes a pipeline of over 100 investigational agents for moderate to severe ulcerative colitis.
New ulcerative colitis drugs show over 25% remission in early trials, offering hope for the 20% of patients hospitalized within five years o…